Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr-Jun;7(2):193-7.
doi: 10.4103/0974-8490.150541.

A study of Nigella sativa induced growth inhibition of MCF and HepG2 cell lines: An anti-neoplastic study along with its mechanism of action

Affiliations

A study of Nigella sativa induced growth inhibition of MCF and HepG2 cell lines: An anti-neoplastic study along with its mechanism of action

Y Padmanabha Reddy et al. Pharmacognosy Res. 2015 Apr-Jun.

Abstract

Objective: To evaluate the anticancer potential of seeds of Nigella sativa using MCF and HepG2 cell lines along with its mechanism of action.

Materials and methods: (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and acridine orange/ethidium bromide nuclear staining technique were selected to evaluate anticancer potential and mechanism of action of test extract.

Results: Aqueous extract of N.sativa at a test dose of 180 mg and 300 mg was identified to be the best as anticancer agent against MCF and HepG2 cell lines among different solvent test extract where doxorubicin and cisplatin were employed as standard references.

Discussion: Further study including separation and characterization of active principles in the aqueous extract shall prove beneficial.

Keywords: Anti-neoplastic; HepG2; Nigella sativa seeds; Nuclear staining; human breast adenocarcinoma cells.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
MCF cells without standard or test substances
Figure 2
Figure 2
Cisplatin treated (standard drug)
Figure 3
Figure 3
Autonomic nervous system treated (test drug)
Figure 4
Figure 4
Comparative graphical representation of effect of standard and test drug on the MCF cell lines

References

    1. Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. World Health Organization; 2001. [Last accessed on 2014 Apr 10]. Cancer incidence, mortality and survivalby site for 14 regions of the world. Global Programme on Evidence for Health Policy Discussion; pp. 3–49. Available from: http://www.who.int/evidence .
    1. Imran A, Wani WA, Saleem K. Cancer scenario in India with future perspectives. Cancer Ther. 2011;8:56–70.
    1. Murthy NS, Mathew A. Cancer epidemiology, prevention and control. Curr Sci. 2004;86:518–27.
    1. Globocon 2008 Data: Number of Cases of Breast Cancer in India. Breast Cancer Incidence Comparision: INDIA – US. [Last accessed on 2014 Apr 10]. Available from: http://www.breastcancerindia.net/bc/statistics/stat_global.htm .
    1. Dhillon PK. South Asia Network for Chronic Diseases, Public Health Foundation of India. Breast Cancer Factsheet. [Last accessed on 2014 Apr 10]. Available from: http://www.saned.org/breast%20cancer%20factsheet%2003.11.11.pdt .

LinkOut - more resources